NASDAQ: CRMD
Cormedix Inc Stock Ownership - Who owns Cormedix?

Insider buying vs selling

Have Cormedix Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph TodiscoChief Executive Officer2026-01-2327,306$7.27
$198.51kSell
Susan BlumChief Financial Officer2026-01-239,767$7.27
$71.01kSell
Kaufman Beth ZelnickChief Legal Officer2026-01-238,803$7.27
$64.00kSell
Elizabeth HurlburtChief Operating Officer2026-01-2310,778$7.27
$78.36kSell
Janet DillioneDirector2026-01-2110,000$6.88
$68.80kSell
Joseph TodiscoChief Executive Officer2026-01-1722,665$6.78
$153.67kSell
Joseph TodiscoChief Executive Officer2026-01-1629,585$3.38
$100.00kBuy
Elizabeth HurlburtChief Operating Officer2026-01-125,794$7.15
$41.43kSell
Joseph TodiscoChief Executive Officer2026-01-1217,417$7.15
$124.53kSell
Steven W. LefkowitzDirector2026-01-1215,000$5.63
$84.45kBuy

1 of 5

CRMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRMD insiders and whales buy or sell their stock.

CRMD Shareholders

What type of owners hold Cormedix Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.22%5,688,303$46.47MInstitution
Vanguard Group Inc5.05%3,977,658$32.50MInstitution
Marshall Wace LLP4.41%3,473,494$28.38MInstitution
Deerfield Management Company LP4.22%3,323,833$27.16MInstitution
Gary A. Gelbfish3.48%2,739,743$22.38MInsider
State Street Corp2.33%1,835,621$15.00MInstitution
Geode Capital Management LLC2.30%1,809,772$14.79MInstitution
Citadel Advisors LLC2.18%1,717,087$14.03MInstitution
Alyeska Investment Group LP1.60%1,262,979$10.32MInstitution
Ubs Group Ag1.38%1,090,908$8.91MInstitution

1 of 3

CRMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRMD54.72%9.50%Net SellingNet Selling
MGTX57.28%42.72%Net SellingNet Selling
RIGL37.73%62.27%Net SellingNet Buying
DRTS2.15%0.00%
GOSS77.81%15.24%Net Buying

Cormedix Stock Ownership FAQ

Who owns Cormedix?

Cormedix (NASDAQ: CRMD) is owned by 54.72% institutional shareholders, 9.50% Cormedix insiders, and 35.79% retail investors. Gary A. Gelbfish is the largest individual Cormedix shareholder, owning 2.74M shares representing 3.48% of the company. Gary A. Gelbfish's Cormedix shares are currently valued at $22.25M.

If you're new to stock investing, here's how to buy Cormedix stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.